Waters (NYSE:WAT) Price Target Increased to $358.00 by Analysts at TD Cowen

Waters (NYSE:WAT) had its price target hoisted by stock analysts at TD Cowen from $350.00 to $358.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the medical instruments supplier’s stock. TD Cowen’s price target suggests a potential upside of 9.77% from the stock’s previous close.

WAT has been the topic of several other research reports. Barclays increased their price target on shares of Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a research report on Monday, February 12th. Stifel Nicolaus raised their target price on Waters from $330.00 to $332.00 and gave the company a “hold” rating in a report on Wednesday. Evercore ISI lifted their price target on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Finally, Robert W. Baird decreased their target price on Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating and ten have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Waters has an average rating of “Hold” and an average price target of $307.20.

Waters Price Performance

NYSE WAT traded up $0.07 during midday trading on Wednesday, hitting $326.13. The company had a trading volume of 126,108 shares, compared to its average volume of 417,145. The company has a market capitalization of $19.34 billion, a PE ratio of 30.13, a P/E/G ratio of 6.39 and a beta of 0.98. Waters has a twelve month low of $231.90 and a twelve month high of $363.80. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The firm has a 50-day moving average price of $333.23 and a 200-day moving average price of $310.76.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating analysts’ consensus estimates of $2.10 by $0.11. The business had revenue of $636.80 million during the quarter, compared to the consensus estimate of $635.57 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. Waters’s revenue for the quarter was down 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.49 earnings per share. As a group, analysts anticipate that Waters will post 11.89 earnings per share for the current fiscal year.

Insider Buying and Selling at Waters

In related news, Director Linda Baddour sold 500 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the sale, the director now directly owns 2,250 shares in the company, valued at $799,965. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.82% of the company’s stock.

Institutional Trading of Waters

Institutional investors have recently added to or reduced their stakes in the stock. Indiana Trust & Investment Management CO acquired a new stake in Waters during the 1st quarter worth about $25,000. Riverview Trust Co acquired a new stake in Waters during the first quarter worth approximately $28,000. Exchange Traded Concepts LLC bought a new stake in Waters in the fourth quarter worth approximately $35,000. Annis Gardner Whiting Capital Advisors LLC acquired a new position in Waters in the third quarter valued at approximately $33,000. Finally, Wetzel Investment Advisors Inc. bought a new position in shares of Waters during the 4th quarter worth approximately $39,000. 94.01% of the stock is currently owned by institutional investors.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.